Public funding and pricing
Public funding and pricing The Norwegian Medical Products Agency is responsible for assessing the cost-effectiveness of prescription-only-medicines and for setting maximum prices.
Increased focus on joint European health technology assessments
Published:
|
Updated:
NOMA director new head of European health technology assessment network
Published:
Important information regarding preparation of documentation packages for health technology assessments
Published:
Changes to the Submission Process for Documentation in Health Technology Assessments from September 1st
Published:
|
Updated: